Financial Year |
March 31 2023 |
Monetary Funds |
135,951,749.62 |
Held-for-trading Financial Assets |
4,608,000.00 |
Notes Receivable |
102,305,143.21 |
Accounts Receivable |
692,671,432.69 |
Advances to Suppliers |
40,762,289.59 |
Other Receivables |
7,223,457.99 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
421,870,337.71 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
69,366,168.70 |
Total Current Assets |
1,554,153,369.23 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
2,659,418.24 |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
470,525,420.11 |
Under-construction Projects |
32,120,714.31 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
101,767,829.81 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
28,182,427.05 |
Deferred Income Tax Assets |
51,980,199.09 |
Other Non-Current Assets |
16,198,110.79 |
Sub-Total of Non-Current Assets |
756,088,082.52 |
Total Assets |
2,310,241,451.75 |
Short-Term Loans |
418,000,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
197,305,000.00 |
Accounts Payable |
261,336,978.29 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
26,353,775.84 |
Taxes Payable |
14,903,998.96 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
3,243,963.73 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
25,809,909.99 |
Other Current Liabilities |
26,103,393.14 |
Sub-Total of Current Liabilities |
993,281,965.75 |
Long-term Loans |
72,959,150.20 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
1,188,304.77 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
144,970,350.70 |
Total Liabilities |
1,138,252,316.45 |
Paid-In Capital(Or Share Stock) |
720,000,000.00 |
Capital Surplus |
60,724,090.63 |
Surplus Reserve |
43,454,795.26 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
334,860,365.11 |
Minority Stockholder's Interest |
16,426,731.60 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,155,562,403.70 |
Owner's Equity(Stockholder's Equity) |
1,171,989,135.30 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,310,241,451.75 |